Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular ...
Duke University and Duke-NUS Medical School are proud to announce the recipients of their latest Research Collaboration Pilot Project grants, totalling more than S$1 million. These grants underscore ...
THE Georgetown Public Hospital Corporation (GPHC) has successfully hosted its second Annual Research Day 2025 under the theme: “Advancing Surgical Excellence: ...
Weekly Trust on MSN4h
Reverse medical tourismA few days ago, the coordinating Minister of Health and Social Welfare, while briefing State House correspondents, disclosed that, 'People are now beginning to come to Nigeria from the region to ...
19h
WLKY Louisville on MSNThe 'rose rush' is on this Valentine's Day in Louisville, but florists noticing some changesAccording to the American Society of Florists, nationally, about 250,000,000 roses are grown just for Valentine's Day. In Westport Village, the store manager at Oberer's Flowers, Sarah Niner, ...
The BC Cancer Foundation has launched a $6.8 million fundraising campaign to expand provincial immunotherapy research program ...
The biotechnology company, Ultragenyx, has reported a successful fourth quarter and full year 2024 financial results ...
Brothers Sam and Tom Stith were attached at the hip for most of their lives. Where Sam went, Tom went too — including their ...
"Heart failure and kidney failure often go hand in hand," he told Newsweek, adding that the kidneys control the way the body handles salt and water. If they are not getting rid of these substances ...
As Jimmy Cleverly's health declined it became clear he needed a kidney transplant. No one in his family was a viable donor, but as fate would have it, his wife Ashley was a perfect match.
The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...
Casas, MD, discusses a systematic review of recent trials examining objective response rate and adverse events of antibody drug conjugate (ADC) combinations in advanced urothelial cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results